GeneFerm Biotechnology Co., Ltd. Stock

Equities

1796

TW0001796001

Food Processing

End-of-day quote Taipei Exchange 06:00:00 2024-05-30 pm EDT 5-day change 1st Jan Change
62.3 TWD +0.48% Intraday chart for GeneFerm Biotechnology Co., Ltd. -3.26% -16.38%
Sales 2022 634M 19.53M Sales 2023 794M 24.45M Capitalization 3.09B 95.15M
Net income 2022 93M 2.86M Net income 2023 125M 3.85M EV / Sales 2022 4.5 x
Net Debt 2022 80.33M 2.47M Net Debt 2023 7.29M 225K EV / Sales 2023 3.9 x
P/E ratio 2022
30.3 x
P/E ratio 2023
24.9 x
Employees -
Yield 2022
2.24%
Yield 2023
2.68%
Free-Float 45.07%
More Fundamentals * Assessed data
Dynamic Chart
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
More news
1 day+0.48%
1 week-3.26%
1 month+12.86%
3 months+3.32%
6 months-22.32%
Current year-16.38%
More quotes
1 week
62.00
Extreme 62
65.10
1 month
54.30
Extreme 54.3
68.30
Current year
53.30
Extreme 53.3
74.80
1 year
53.30
Extreme 53.3
138.00
3 years
30.70
Extreme 30.7
158.50
5 years
18.50
Extreme 18.5
158.50
10 years
18.50
Extreme 18.5
158.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - 07-06-13
Director of Finance/CFO - 05-03-27
Chairman - 04-06-30
Members of the board TitleAgeSince
Director/Board Member - 07-06-13
Director/Board Member - 16-06-20
Director/Board Member 52 16-06-20
More insiders
Date Price Change Volume
24-05-31 62.3 +0.48% 44,742
24-05-30 62 -2.97% 84,400
24-05-29 63.9 +0.16% 43,530
24-05-28 63.8 -0.47% 43,332
24-05-27 64.1 -0.47% 36,515

End-of-day quote Taipei Exchange, May 30, 2024

More quotes
GeneFerm Biotechnology Co., Ltd. is a Taiwan-based company mainly engaged in the manufacture and sales of health food. Its health food products include fermented products, medicinal mushrooms, lactic acid bacteria products, fruit and vegetable fermented concentrate products, among others. The Company also provides related manufacturing services, as well as health food design, research and development services.
More about the company